21sme.com

Featured Links

FDA to review Vytorin cholesterol drug study (Reuters)

Date : 25 Jan 2008 Category : Business

Yahoo! News: Business

Last news | Popular News | News Archive

Reuters - U.S. regulators said on Friday they would review a study showing a Merck and Schering-Plough cholesterol drug worked no better than a generic in preventing the build-up of arterial plaque.

More News

Home loan troubles break records again (AP)

Wall Street flat as financials offset weak data (Reuters)

Jobless rate at 5-year high (Reuters)

Home foreclosures reach record high (Reuters)

Executive leaves hedge fund Citadel (Reuters)

Continental introduces $15 fee for 1st checked bag (Reuters)

The Last Thing A Musician Wants These Days Is To Appear Anti-Fan

Comcast Appeals FCC's Wrist Slap

Dell plans to sell computer factories: report (Reuters)

IBM Seeks Patent For Biosensor-Based Hiring

HP And Walmart Get Rid Of Laptop Box; Buy The Computer And Get It In A Messenger Bag

Lone Star may sue S.Korea govt on KEB deal: paper (Reuters)

Once More, With Feeling: The Internet Isn't At Risk Of Running Out Of Bandwidth

Boeing workers frustrated, angry at strike delay (Reuters)

Hedge fund Atticus denies liquidation rumors: report (Reuters)

California: We Charge People To Read Our Laws For The Benefit Of Californians

Citibank Had A Program To Take Money From Customers?

Lehman weighs real estate spinoff: report (Reuters)

Global growth, U.S. job fears hammer Wall Street (Reuters)

Slow August sales signal more weakness in retail (AP)